(6-((5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methanol

Catalog No. :
ACVZOB394
CAS No. :
1648707-16-7
Molecular Formula :
C21H20F2N6O
Molecular Weight :
410.43

IUPAC Name:(6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methanol

(6-((5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-((5-Fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methanol
IUPAC Name(6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methanol
Molecular FormulaC21H20F2N6O
Molecular Weight410.43
SMILESCC1=NC2=C(C=C(C3=NC(NC4=CC=C(CO)C=N4)=NC=C3F)C=C2F)N1C(C)C
InChI KeyACVBSYVEBTUCCX-UHFFFAOYSA-N
Synonym3-Pyridinemethanol, 6-[[5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinyl]amino]-;(6-((5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amino)pyridin-3-yl)methanol;Abesili impurity 13;6-[[5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazole-6-yl]-2-pyrimidinyl]amino]-3-pyridine methanol
CAS No.1648707-16-7

Synthetic Route by SureRoute

1. ACVZOB394 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVZOB394 route product structure diagram
    ACVZOB3941648707-16-7
Inquiry

2. ACVZOB394 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVZOB394 route product structure diagram
    ACVZOB3941648707-16-7
Inquiry

Comments (0)